[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2002032938A3 - Regulation of human pgc-1-like protein - Google Patents

Regulation of human pgc-1-like protein Download PDF

Info

Publication number
WO2002032938A3
WO2002032938A3 PCT/EP2001/011924 EP0111924W WO0232938A3 WO 2002032938 A3 WO2002032938 A3 WO 2002032938A3 EP 0111924 W EP0111924 W EP 0111924W WO 0232938 A3 WO0232938 A3 WO 0232938A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
human pgc
regulation
reagents
pgc
Prior art date
Application number
PCT/EP2001/011924
Other languages
French (fr)
Other versions
WO2002032938A2 (en
Inventor
Timothy J Smith
Original Assignee
Bayer Ag
Timothy J Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Timothy J Smith filed Critical Bayer Ag
Priority to AU2002215956A priority Critical patent/AU2002215956A1/en
Publication of WO2002032938A2 publication Critical patent/WO2002032938A2/en
Publication of WO2002032938A3 publication Critical patent/WO2002032938A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Reagents which regulate human PGC-1-like protein and reagents which bind to human PGC-1-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, obesity, cardiovascular disorders, diabetes, and COPD.
PCT/EP2001/011924 2000-10-17 2001-10-16 Regulation of human pgc-1-like protein WO2002032938A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002215956A AU2002215956A1 (en) 2000-10-17 2001-10-16 Regulation of human pgc-1-like protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24084400P 2000-10-17 2000-10-17
US60/240,844 2000-10-17

Publications (2)

Publication Number Publication Date
WO2002032938A2 WO2002032938A2 (en) 2002-04-25
WO2002032938A3 true WO2002032938A3 (en) 2002-11-07

Family

ID=22908175

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011924 WO2002032938A2 (en) 2000-10-17 2001-10-16 Regulation of human pgc-1-like protein

Country Status (2)

Country Link
AU (1) AU2002215956A1 (en)
WO (1) WO2002032938A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514921A (en) * 2001-11-09 2005-05-26 ダナ−ファーバー キャンサー インスティチュート インク PGC-1β, novel PGC-1 homologue and use thereof
US7947652B2 (en) * 2004-09-03 2011-05-24 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating PGC-1α to treat huntington's disease
ES2397889B1 (en) 2011-03-25 2014-02-07 Lipotec, S.A. MODULATING PEPTIDES OF PGC-1 Alpha.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032215A1 (en) * 1998-12-01 2000-06-08 Dana-Farber Cancer Institute PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032215A1 (en) * 1998-12-01 2000-06-08 Dana-Farber Cancer Institute PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ESTERBAUER HARALD ET AL: "Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 62, no. 1, 15 November 1999 (1999-11-15), pages 98 - 102, XP002181538, ISSN: 0888-7543 *
LARROUY D ET AL: "CLONING AND MRNA TISSUE DISTRIBUTION OF HUMAN PPARGAMMA COACTIVATOR-1", INTERNATIONAL JOURNAL OF OBESITY, NEWMAN PUBLISHING, LONDON, GB, vol. 23, no. 12, December 1999 (1999-12-01), pages 1327 - 1332, XP001022168, ISSN: 0307-0565 *

Also Published As

Publication number Publication date
WO2002032938A2 (en) 2002-04-25
AU2002215956A1 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
WO2002036754A3 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
WO2002020731A3 (en) Regulation of human protein disulfide isomerase-like enzyme
WO2002072824A3 (en) Human transient receptor potential channel protein.
WO2002032938A3 (en) Regulation of human pgc-1-like protein
WO2001077149A3 (en) Regulation of human cyslt2-like gpcr protein
WO2002062974A3 (en) Regulation of human elongase hselo1-like protein
WO2003004629A3 (en) Regulation of human citron rho/rac-interacting kinase-short kinase
WO2002055712A3 (en) Regulation of human alanine aminotransferase
WO2002036731A3 (en) Human lysosomal acid lipase
WO2002036613A3 (en) Regulation of human patched-like protein
WO2002062975A3 (en) Regulation of human elongase hselo1-like protein
WO2002046403A3 (en) Regulation of human patched-like protein
WO2003052088A3 (en) Regulation of human sialyltransferase
WO2002033056A3 (en) Regulation of human serine-threonine protein kinase
WO2002026999A3 (en) Regulation of human adam-ts-like protein
WO2002081705A3 (en) Regulation of human gnat acetyltransferase-like protein
WO2002099106A3 (en) Regulation of human secretin -type gpcr
WO2002033080A3 (en) Regulation of human netrin binding membrane receptor unc5h-1
WO2002081704A3 (en) Regulation of human protein kinase-like protein
WO2003016515A3 (en) Regulation of human glycerol-3-phosphate acyltransferase-like protein
WO2002024731A3 (en) Regulation of human fgd1-like protein
WO2002046402A3 (en) Regulation of human patched-like protein
WO2002055710A3 (en) Regulation of human purple acid phosphatase
WO2002072825A3 (en) Human mrp5-like protein
WO2003025174A3 (en) Regulation of human mrp1-like protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 10399140

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP